- B2B
- Growth StageExpanding market presence
Unlearn.AI careers
Clinical trials are risky and can dramatically extend the time needed to fully develop a new therapy. This profound problem has found a paradigm-transforming solution. Unlearn is a science-first company that has created the first machine learning platform for populating Intelligent Control Arms with perfectly matched Digital Twins.
Intelligent Control Arms expedite patient recruitment, increase study power, and provide patient-level treatment response information. It’s about increasing confidence in trial results. It’s about bringing new medicines to patients faster.
It’s about time.
Intelligent Control Arms expedite patient recruitment, increase study power, and provide patient-level treatment response information. It’s about increasing confidence in trial results. It’s about bringing new medicines to patients faster.
It’s about time.
Unlearn.AI hasn't added any jobs yet
Get notified when Unlearn.AI posts new jobs.
Jonathan Walsh
Co-founded Unlearn.AI. Data science and machine learning background. PhD in theoretical physics.
Aaron Smith
PhD, Mathematics UPenn. ML and Software.
Charles Fisher
Founder, machine learning scientist and health care entrepreneur. Harvard Biophysics PhD; University of Michigan Biophysics BS;
Valuation
$0
Funded over
2 rounds
Latest round
Seed (Mar 2019)
AllTrails • San Francisco • $85k – $110k • 3 days ago
Noble Biomaterials • Scranton • $64k – $84k • 7 days ago
Brightidea, Inc. • San Francisco • $150k – $300k • 1 week ago
Syndax Pharmaceuticals • New York City • 2 weeks ago
Akebia Therapeutics • Oakland • $178k – $220k • 2 weeks ago
